CLINICAL_TRIALS
trial_result
· 2022-06-16
Clinical Trial Update: An Innovative Trial Assessing Donor Sex on Recipient Mortality [Phase 4]
Summary
Phase 4 trial evaluating whether donor sex influences recipient mortality in red blood cell transfusion. Status is currently UNKNOWN.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Ottawa Hospital Research Institute | Conditions: Red Blood Cell Transfusion | Phase 4 | Status: UNKNOWN